MediWound Ltd.
MDWD- Exchange
- Nasdaq
- Industry
- Medicinal Chemicals & Botanical Products
- SEC CIK
- 0001593984
In the last 90 days, MediWound Ltd. insiders filed 1 open-market purchase and 2 sales; 78 institutions reported holding it in 13F filings for Q2 2026, worth $85.5M in total; ARK Invest is the only superinvestor holding it.
Q3 2022 vs. Q2 2022
How the institutions holding MediWound Ltd. changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Q3 2022 | Change |
|---|---|---|---|
| Holders | 20 | 28 | +8 |
| Shares | 3.06M | 8.73M | +5.67M (+185.4%) |
| Value | $5.63M | $12.2M | +$6.53M (+116.0%) |
New holders (8)
Institutions that held MediWound Ltd. at the end of Q3 2022 but not at the end of Q2 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Armistice Capital, LLC | 1,915,520 | $2.66M | 0.07% |
| DAFNA Capital Management LLC | 1,428,571 | $1.99M | 0.53% |
| Altium Capital Management LP | 1,276,948 | $1.77M | 0.67% |
| Sphera Funds Management Ltd. | 688,716 | $958.0K | 0.17% |
| Essex Investment Management Co LLC | 291,286 | $405.0K | 0.06% |
| Group One Trading, L.P. | 8,800 | $12.0K | 0.00% |
| MUFG Americas Holdings Corp | 1,600 | $2.00K | 0.00% |
| Bank of America Corp | 314 | $0 | 0.00% |
Sold out (0)
Institutions that held MediWound Ltd. at the end of Q2 2022 and filed for Q3 2022 without it.
None.